Literature DB >> 2148681

An essential proline in lambda repressor is required for resistance to intracellular proteolysis.

J F Reidhaar-Olson1, D A Parsell, R T Sauer.   

Abstract

Pro78 is a solvent-exposed residue at the N-terminal end of alpha-helix 5 in the DNA binding domain of lambda repressor. Random mutagenesis experiments have suggested that Pro78 is essential [Reidhaar-Olson, J.F., & Sauer, R.T. (1990) Proteins: Struct., Funct., Genet. (in press)]. To investigate the requirement for proline at this position, we constructed and studied the properties of a set of ten position 78 mutant proteins. All of these mutants have decreased intracellular activities and are expressed at significantly lower levels than wild type. Pulse-chase experiments show that the mutant proteins are rapidly degraded in the cell; the mutants examined had half-lives of 11-35 min, whereas the wild-type protein has a half-life of greater than 10 h. The rapid degradation of position 78 mutants is not suppressed by mutations that affect known Escherichia coli proteases. The Pro78----Ala mutant could be overexpressed in a dnaJ- strain and was purified. This mutant has full DNA binding activity in vitro, suggesting that its folded structure and ability to form active dimers are similar to those of wild type. The PA78 mutant (Tm = 48 degrees C) is less thermally stable than wild type (Tm = 55 degrees C). Double-mutant studies show that this instability contributes to but is not the main cause of its rapid intracellular degradation and also suggest that proteolysis proceeds from the denatured forms of proteins containing the PA78 substitution. The PA78 mutation does not appear to introduce a new cleavage site for cellular proteases, nor does the mutation enhance susceptibility to proteases such as thermolysin and trypsin in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148681     DOI: 10.1021/bi00485a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Thermodynamics of replacing an alpha-helical Pro residue in the P40S mutant of Escherichia coli thioredoxin.

Authors:  A Chakrabarti; S Srivastava; C P Swaminathan; A Surolia; R Varadarajan
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Contributions of a hydrogen bond/salt bridge network to the stability of secondary and tertiary structure in lambda repressor.

Authors:  S Marqusee; R T Sauer
Journal:  Protein Sci       Date:  1994-12       Impact factor: 6.725

3.  P22 Arc repressor: enhanced expression of unstable mutants by addition of polar C-terminal sequences.

Authors:  M E Milla; B M Brown; R T Sauer
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

4.  Structural stability of Bacillus thuringiensis delta-endotoxin homolog-scanning mutants determined by susceptibility to proteases.

Authors:  B D Almond; D H Dean
Journal:  Appl Environ Microbiol       Date:  1993-08       Impact factor: 4.792

5.  Analysis of the structure and stability of omega loop A replacements in yeast iso-1-cytochrome c.

Authors:  J S Fetrow; S R Horner; W Oehrl; D L Schaak; T L Boose; R E Burton
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

6.  Conserved Apical Proline Regulating the Structure and DNA Binding Properties of Helicobacter pylori Histone-like DNA Binding Protein (Hup).

Authors:  Nipanshu Agarwal; Nupur Nagar; Ritu Raj; Dinesh Kumar; Krishna Mohan Poluri
Journal:  ACS Omega       Date:  2022-04-18

7.  In silico molecular engineering for a targeted replacement in a tumor-homing peptide.

Authors:  David Zanuy; Alejandra Flores-Ortega; Ana I Jiménez; M Isabel Calaza; Carlos Cativiela; Ruth Nussinov; Erkki Ruoslahti; Carlos Alemán
Journal:  J Phys Chem B       Date:  2009-06-04       Impact factor: 2.991

8.  A pathway for targeting soluble misfolded proteins to the yeast vacuole.

Authors:  E Hong; A R Davidson; C A Kaiser
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.